Further genetic testing showed that there was a large heterozygous deletion mutation in the exon region of the Peripheral myelin protein-22 (PMP22) gene of the patient (Fig. 1), thus the final diagnosis was HNPP. This evidence concerns the gene PMP22 and hereditary neuropathy with liability to pressure palsies.